Ram Kandasamy, PhD Faculty Profile

Photo of Ram Kandasamy

Ram  Kandasamy, PhD

Associate Professor

Department of Psychology

Dr. Kandasamy is an Associate Professor in the Department of Psychology at ߣߣÊÓÆµ, East Bay, where he has been a faculty member since 2019 and was awarded early tenure and promotion in 2024. At Cal State East Bay, Dr. Kandasamy teaches courses including Physiological Psychology (PSYC 320), Experimental Psychology (PSYC 300), Drugs and Behavior (PSYC 420), and Research in Physiological Psychology (PSYC 491B), and serves as a major advisor. Dr. Kandasamy currently leads two active research projects both funded by the National Institutes of Health focused on developing non-opioid treatments for chronic pain, including the evaluation of multitarget enzyme inhibitors for orofacial and inflammatory pain. His research integrates behavioral neuroscience, pharmacology, and translational pain models and actively involves undergraduate students at every stage. Many of his trainees have published, received national recognition, and presented their work at professional conferences.

Dr. Kandasamy has published extensively with his students and co-authored book chapters on pain mechanisms, measurement, and therapies. He has served on multiple national review panels and professional committees, including executive roles within the American Society for Pharmacology and Experimental Therapeutics (ASPET), the North American Pain School, and as a member of the Faculty Consensus Group of CSUBIOTECH, where he contributes to system-wide efforts supporting biotechnology research and education across the CSU.

Dr. Kandasamy served as the Faculty Fellow for the Center for Student Research from 2022-2025 and served as its Interim Director in Summer 2023. He is currently the Principal Investigator of the university’s Beckman Scholars Program, funded by the Arnold & Mabel Beckman Foundation. His leadership is rooted in undergraduate research, with a strong emphasis on mentorship and student development.

Dr. Kandasamy earned his B.S. in Neuroscience and Psychology, magna cum laude, from Washington State University in Pullman, WA, where he studied sex differences in cannabinoid analgesia with Dr. Rebecca Craft. He completed his Ph.D. in Neuroscience at Washington State University in Vancouver, WA, under the mentorship of Dr. Michael Morgan, pioneering a novel behavioral measure of pain and analgesia using wheel running in rodents. He later trained as a postdoctoral fellow in the Department of Pharmacology at the University of Michigan Medical School with Dr. John Traynor, where he examined the analgesic and abuse-related properties of opioid drugs.

Prospective CSUEB students interested in hands-on neuroscience research focused on pain and analgesia are encouraged to contact Dr. Kandasamy directly to explore opportunities in his lab.

  • BS (2012), Neuroscience, Psychology; Washington State University (Pullman, WA); Mentor: R. Craft
  • PhD (2017), Neuroscience; Washington State University (Vancouver, WA); Mentor: M. Morgan
  • Postdoc (2019), Pharmacology; University of Michigan Medical School (Ann Arbor, MI); Mentor: J. Traynor

Not teaching this semester.


  1. Carr D.F,UG (Nursing '23), Gunari S.F,UG (Speech Pathology and Audiology '25), Gorostiza G.PB (PHAP '24), Mercado M.UG (Biological Sciences '27), Pavana L.UG (Biological Sciences '24), Duong L., Gomez K., Salinas S., Garcia G., Tsang A., Morisseau C., Hammock B.D., Pecic S.C, Kandasamy R.C (2025). Synthesis and evaluation of isoquinolinyl and pyridinyl-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase to alleviate orofacial hyperalgesia in the rat. Biochemistry and Biophysics Reports, 42, 102009. PMID: 40275962.
  2. Yuan C., Tsang A., Berumen M., Rodriguez A., Yun F., Mesic A., Olivares A., Dubon L., Nguyen A., Pavana L.UG (Biological Sciences '24), Mercado M.UG (Biological Sciences '27), Gorostiza G.PB (PHAP '24), Morisseau C., Hammock B.D., Kandasamy R.C, Pecic S.C (2025). Structure-activity relationship studies and pharmacological evaluation of 4-phenylthiazoles as dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors. Bioorganic & Medicinal Chemistry. 121, 118112. PMID: 39983408.
  3. Carr D.F,UG<